BioSpace News Archive

Masimo (NASDAQ: MASI) will release second quarter 2020 financial results for the period ended June 27, 2020, after the market closes on Tuesday, July 28, 2020. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice Pre

Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced the Company, through its affiliates, entered into a definitive agreement (the “Agreement”) to acquire Guangdong Hanfei Investment Management Co., Ltd. (“Hanfei”), marking the 4th acquisitions in 2020.

Cardiva Medical, Inc, an innovator in the field of vascular closure, today announced the completion of a $45 million equity financing round. The equity round included new investor EW Healthcare Partners in addition to Cardiva Medical’s existing major investors, including affiliates of Luther King Capital Management, PTV Healthcare Capital, and Evidity Health Capital, formerly Canepa Healthcare. The company also announced that Robert S. Whi

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, and the leading provider of superficial radiotherapy (SRT), reports that new guidelines issued by the American Society for Radiation Oncology (ASTRO) recommends SRT as the first-line alternative to surgery when treating patients with non-melanoma skin cancer (NMSC).

Aparna Abburi has been named president of Cigna’s Medicare Advantage business.

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its Real Intelligence brand of enabling technology solutions, as well as its new generation handheld robotics platform - the CORI Surgical System.

FDA Staff Gain Rapid Clinical Insight Capability Leveraging the TriNetX Real-World Data and Analytics Platform

IQVIA™ (NYSE:IQV) has announced its collaboration with AstraZeneca (LON: AZN) to accelerate development of a potential new vaccine for COVID-19. This joint initiative is part of the U.S. government’s recently announced Operation Warp Speed project

The CorNeat KPro, the first synthetic cornea that bio-integrates with the eye wall, received approval to begin a clinical trial at Beilinson Hospital, Israel.

Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second-quarter 2020 results on Wednesday, July 29th, 2020, after the market closes.